Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Argenx
Argenx
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Vyvgart
Efgartigimod alfa
2021-12-17
Myasthenia gravis
,
Extravasation of diagnostic and therapeutic materials
Vyvgart hytrulo
Efgartigimod alfa
,
Hyaluronidase
2023-06-20
Extravasation of diagnostic and therapeutic materials
,
Breast neoplasms
,
Gastrointestinal neoplasms
,
Multiple myeloma
,
Non-small-cell lung carcinoma
,
Urinary bladder neoplasms
,
Multiple sclerosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Hyaluronidase
healthy volunteers/patients
,
neuritis
,
optic neuritis
Efgartigimod alfa
healthy volunteers/patients
,
therapeutic equivalency
,
renal insufficiency
,
syndrome
,
polyneuropathies
,
chronic inflammatory demyelinating polyradiculoneuropathy
,
postural orthostatic tachycardia syndrome
,
tachycardia
,
sjogren's syndrome
,
guillain-barre syndrome
,
kidney diseases
,
membranous glomerulonephritis
,
lupus nephritis
,
nephritis
,
neuritis
,
optic neuritis
,
myasthenia gravis
,
muscle weakness
,
thrombocytopenic purpura idiopathic
,
thrombocytopenia
,
paresis
,
pemphigus
,
bullous pemphigoid
,
myositis
,
dermatomyositis
,
muscular diseases
,
polymyositis
,
graves ophthalmopathy
,
eye diseases
,
thyroid diseases
Hyaluronidase (human recombinant)
healthy volunteers/patients
,
pemphigus
,
bullous pemphigoid
,
myositis
,
dermatomyositis
,
muscular diseases
,
polymyositis
Benzocaine
myasthenia gravis
,
muscle weakness
Transplatin
neoplasms
,
nasopharyngeal carcinoma
Alfacalcidol
syndrome
,
guillain-barre syndrome
Vorhyaluronidase alfa
healthy volunteers/patients
,
pemphigus
,
bullous pemphigoid
,
myositis
,
dermatomyositis
,
muscular diseases
,
polymyositis
Sodium chloride
syndrome
,
guillain-barre syndrome
Bevifimod
neoplasms
CUSATUZUMAB
nasopharyngeal carcinoma
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
neoplasms
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia juvenile
Corticoids
neuritis
,
optic neuritis
Octagam
syndrome
,
guillain-barre syndrome
Q2w
myasthenia gravis
,
muscle weakness
Allograft
delayed graft function
Cms
syndrome
,
lambert-eaton myasthenic syndrome
,
congenital myasthenic syndromes
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use